ONCSM.E — Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapHigh Flyer

Market Cap
TRY5.82bn
Enterprise Value
TRY5.86bn
Revenue
TRY709.08m

Annual balance sheet for Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS, fiscal year end - December 31st, TRY millions except per share, conversion factor applied.

	2021 December 31st	R2022 December 31st	R2023 December 31st	R2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	5.77	19.3	84.5	58.5	45.4
Net Total Accounts Receivable
Net Total Receivables	34.3	78.5	80.6	113	271
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	85.4	199	282	285	404
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	39.3	137	171	188	192
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	130	350	488	501	624
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	44.1	96.3	131	106	155
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	50.8	126	154	142	217
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	78.8	224	335	359	407
Total Liabilities & Shareholders' Equity	130	350	488	501	624
Total Common Shares Outstanding